Relation between preclinical atherosclerosis and venous thromboembolism in patients with thrombophilias -

O Auzký1, R Dembovská, J Mrázková

  • 1Laboratory for Atherosclerosis Research, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. auzky@seznam.cz.

Physiological Research
|November 28, 2014
PubMed

Insights

Patients with thrombophilia and a history of venous thromboembolism (VTE) did not show greater atherosclerosis progression than those without VTE history. Both groups experienced unfavorable changes in body mass index and blood pressure.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Vascular Biology

Background:

  • Preclinical atherosclerosis is a potential risk factor for venous thromboembolism (VTE).
  • Understanding the relationship between atherosclerosis progression and VTE history in thrombophilia patients is crucial.

Purpose of the Study:

  • To investigate the progression of preclinical atherosclerosis in patients with thrombophilia, comparing those with and without a history of VTE.
  • To assess changes in traditional atherosclerosis risk factors in these patient groups over time.

Main Methods:

  • A longitudinal study followed 96 patients with thrombophilia (51 with VTE history, 45 without).
  • Preclinical atherosclerosis was assessed using ultrasound and the Belcaro score.
  • Changes in body mass index, waist circumference, and blood pressure were monitored.

Main Results:

  • No significant change in preclinical atherosclerosis (Belcaro score) was observed in either group over a mean follow-up of 56 months.
  • Both groups showed a significant increase in body mass index and a non-significant increase in systolic blood pressure.
  • Waist circumference increased significantly only in patients without a history of VTE.

Conclusions:

  • Patients with thrombophilia and a history of VTE do not exhibit greater atherosclerosis progression or increased traditional risk factors compared to those without VTE history.
  • Both groups experienced unfavorable changes in body mass index, waist circumference, and blood pressure during the study period.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
780
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
477
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
451
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
400
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
19